Geldanamycin and derivatives inhibit cancer invasion and identify novel targets

Details for Australian Patent Application No. 2005228886 (hide)

Owner Van Andel Research Institute Michigan State University

Inventors Xie, Qian; Wenkert, David; Hay, Rick; Shen, Yuchai; Vande Woude, George F.

Agent Griffith Hack

Pub. Number AU-A-2005228886

PCT Pub. Number WO2005/095347

Priority 60/556,474 26.03.04 US

Filing date 28 March 2005

Wipo publication date 13 October 2005

International Classifications

C07D 225/06 (2006.01) Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/095347 Priority application(s): WO2005/095347

16 November 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 09 Oct 2006

9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005228888-Processes for the production of xylitol

2005228881-Heterocyclic CGRP antagonists for the treatment of migraine